- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Florida Cancer Specialists Researcher Co-Authored SABCS Breast Cancer Study
A member of the clinical research team at Florida Cancer Specialists & Research Institute (FCS) served as co-author of a study presented at San Antonio Breast Cancer Symposium.
Fort Myers, Florida — Medical oncologist James Reeves, MD, a member of the clinical research team at Florida Cancer Specialists & Research Institute (FCS), served as co-author of a study shared in a poster presentation at the San Antonio Breast Cancer Symposium, which was held December 7-12, 2021.
Entitled, “Correlation Between Presence of Circulating Tumor DNA and Response to Neoadjuvant Niraparib in HER2-Negative, BRCA-Mutated Breast Cancer,” the study's analysis indicates a correlation between the TP53 gene and tumor volume following treatment with niraparib over time.
“Mutations in TP53 occur in 30% to 35% of invasive primary breast cancer cases and may be an effective biomarker. Nuraparib, a poly(ADP-ribose) polymerase (PARP)-1/2 inhibitor, provides a new, effective treatment option for BRCA 1/2-mutated early-stage breast cancer after chemotherapy,” said Dr Reeves and fellow researchers.
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers
November 13th 2024Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.
Read More
